Morgan Dempsey Capital Management LLC Lowers Stake in Kewaunee Scientific Corporation (KEQU)
Morgan Dempsey Capital Management LLC decreased its stake in Kewaunee Scientific Corporation (NASDAQ:KEQU) by 3.9% during the second quarter, Holdings Channel reports. The fund owned 12,564 shares of the technology company’s stock after selling 511 shares during the period. Morgan Dempsey Capital Management LLC’s holdings in Kewaunee Scientific Corporation were worth $313,000 as of its most recent filing with the SEC.
Kewaunee Scientific Corporation (NASDAQ:KEQU) opened at 25.639 on Thursday. Kewaunee Scientific Corporation has a 12-month low of $20.95 and a 12-month high of $27.60. The firm’s 50-day moving average is $25.04 and its 200 day moving average is $23.88. The firm has a market cap of $69.53 million, a P/E ratio of 15.445 and a beta of 0.07.
Kewaunee Scientific Corporation (NASDAQ:KEQU) last announced its quarterly earnings data on Tuesday, June 20th. The technology company reported $0.51 EPS for the quarter. The business had revenue of $34.58 million during the quarter. Kewaunee Scientific Corporation had a return on equity of 10.99% and a net margin of 3.26%.
Kewaunee Scientific Corporation Company Profile
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Corporation (NASDAQ:KEQU).
Receive News & Ratings for Kewaunee Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.